BAF312A_MAYZENT_NEUROSCIENCE: payments to doctors
Payments that named BAF312A_MAYZENT_NEUROSCIENCE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $89K
- Providers
- 12
- Transactions
- 45
- Average per transaction
- $1,986
The per-transaction average — $1,986 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12 providers the average total is $7,446, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis Pharma AG | $89,348 | 100.0% |